ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/08/26
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial GuidanceGlobeNewsWire • 05/08/26
ANI Pharmaceuticals (ANIP) is a Top-Ranked Growth Stock: Should You Buy?Zacks Investment Research • 05/06/26
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 05/01/26
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 04/28/26
ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ETGlobeNewsWire • 04/24/26
Is ANIP Stock Undervalued at 10x Forward Earnings and $93 Target?Zacks Investment Research • 04/20/26
ANI Pharmaceuticals' 2026 Catalysts Include Gout Push and New GenericsZacks Investment Research • 04/20/26
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT ExclusivityGlobeNewsWire • 04/20/26
How Much Upside is Left in ANI (ANIP)? Wall Street Analysts Think 41.71%Zacks Investment Research • 04/17/26
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release CapsulesGlobeNewsWire • 04/13/26
ANI Pharmaceuticals Looks Undervalued As Cortrophin Drives Rare Disease GrowthSeeking Alpha • 04/10/26
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate TabletGlobeNewsWire • 04/08/26